Innocan Pharma collaborates with Tel Aviv University to develop a new revolutionary approach to treat the COVID-19 coronavirus with exosomes-loaded CBD

April 20, 2020 Leave a comment 2,378 Views

InnoCan Pharma announced that its wholly-owned subsidiary, InnoCan Pharma Ltd. of Herzliya Israel, has entered into a sponsored research agreement with Ramot at Tel Aviv University to collaborate with Tel Aviv university to develop a novel, revolutionary...

Exosome RNA Exosome RNA Research & Industry News

Tag Archives: Ramot

Innocan Pharma collaborates with Tel Aviv University to develop a new revolutionary approach to treat the COVID-19 coronavirus with exosomes-loaded CBD

Neutralization of SARS-CoV-2 pseudovirus using ACE2-engineered extracellular vesicles

Urine exosome-based liquid biopsy test can can detect and risk-classify prostate cancer with over 90% accuracy

City of Hope and Griffith University researchers use novel method to block HIV in mice

BioFluidica Announces Commercialization of its High Throughput LiquidScan™ Automated Liquid Biopsy System for Capturing Rare Biomarkers on a Single Scalable Platform.

A vesicle-based membrane protein display platform for receptor interactome discovery

Extracellular Vesicles (EVs) – Technologies & Biological Investigations